Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

BGI Group

5 Disclosed Funding Rounds $2,136,308,593

9 Participating Investments $82,976,146


Pharmaceutical, Health Care, Genetics, Biotechnology, Medical, Life Science, Bioinformatics

BGI Group is one of the world’s largest DNA sequencing service providers.

Shenzhen, Guangdong, China, Asia (CN)

Organizations in Shenzhen in Pharmaceutical,
Organizations in Shenzhen in Health Care,
Organizations in Shenzhen in Genetics,
Organizations in Shenzhen in Biotechnology,
Organizations in Shenzhen in Medical,
Organizations in Shenzhen in Life Science,
Organizations in Shenzhen in Bioinformatics,
Organizations in Guangdong in Pharmaceutical,
Organizations in Guangdong in Health Care,
Organizations in Guangdong in Genetics,
Organizations in Guangdong in Biotechnology,
Organizations in Guangdong in Medical,
Organizations in Guangdong in Life Science,
Organizations in Guangdong in Bioinformatics,
Organizations in China in Pharmaceutical,
Organizations in China in Health Care,
Organizations in China in Genetics,
Organizations in China in Biotechnology,
Organizations in China in Medical,
Organizations in China in Life Science,
Organizations in China in Bioinformatics,
Organizations in Asia in Pharmaceutical,
Organizations in Asia in Health Care,
Organizations in Asia in Genetics,
Organizations in Asia in Biotechnology,
Organizations in Asia in Medical,
Organizations in Asia in Life Science,
Organizations in Asia in Bioinformatics

Investors in Shenzhen in Pharmaceutical,
Investors in Shenzhen in Health Care,
Investors in Shenzhen in Genetics,
Investors in Shenzhen in Biotechnology,
Investors in Shenzhen in Medical,
Investors in Shenzhen in Life Science,
Investors in Shenzhen in Bioinformatics,
Investors in Guangdong in Pharmaceutical,
Investors in Guangdong in Health Care,
Investors in Guangdong in Genetics,
Investors in Guangdong in Biotechnology,
Investors in Guangdong in Medical,
Investors in Guangdong in Life Science,
Investors in Guangdong in Bioinformatics,
Investors in China in Pharmaceutical,
Investors in China in Health Care,
Investors in China in Genetics,
Investors in China in Biotechnology,
Investors in China in Medical,
Investors in China in Life Science,
Investors in China in Bioinformatics,
Investors in Asia in Pharmaceutical,
Investors in Asia in Health Care,
Investors in Asia in Genetics,
Investors in Asia in Biotechnology,
Investors in Asia in Medical,
Investors in Asia in Life Science,
Investors in Asia in Bioinformatics

Asia-Pacific (APAC) (0 Investors) (0 Startups)

Founded date 11, 1999

Founders Huanming Yang

Operating Status Active

Funding Stage IPO

Last Funding Type Post-IPO Equity

Also known as 华大基因 , Huada Gene, Huada Jiyin, BGI Genomics

Company Type For Profit


Facebook Link

Twitter Link

LinkedIN Link

Wikipedia Link

Shenzhen Huada Gene Technology Co. Ltd. operates as a biotech development company. The Company provides bioinformatics testing, genetic testing, agricultural genomics researching, proteomics researching, and other services. Shenzhen Huada Gene Technology conducts business in China.

Date Round Raised Lead
February, 22, 2021 Post-IPO Equity $300,000,000 State Development & Investment Corporation (SDIC)
June, 01, 2015 Venture - Series Unknown $323,508,593 Taikang Life Insurance
September, 01, 2012 Venture - Series Unknown Undisclosed -------
January, 10, 2010 Debt Financing $1,500,000,000 China Development Bank International Investment
January, 01, 2007 Grant $12,800,000 Shenzhen Capital Group

BGI Group Participated In the Following Investment Rounds (9)

Organization Name Lead? Round Partners Participating Raise Date
Gooal Gene Yes Seed ------- $1,400,000 November, 21, 2019
Beijing Gene+ Technology No Series B ------- $28,000,000 September, 30, 2019
USCI medical loboratary No Venture - Series Unknown ------- $7,438,373 April, 24, 2019
Beijing Gene+ Technology Yes Undisclosed ------- $7,387,706 January, 14, 2019
CreateCare Yes Series A ------- $3,000,000 December, 07, 2018
F&S Pharmatech No Series A ------- $7,280,140 September, 30, 2018
Genedock No Series B ------- $7,308,300 August, 06, 2018
Congenica No Series B ------- Undisclosed April, 27, 2017
Beijing Gene+ Technology Yes Series A ------- $30,000,000 September, 14, 2016

BGI Group Investors (6)

Investor Lead? Round Participating Raise Date Partners
State Development & Investment Corporation (SDIC) Yes Post-IPO Equity $300,000,000 February, 22, 2021 -------
MSA Capital No Venture - Series Unknown $323,508,593 June, 01, 2015 -------
Taikang Life Insurance Yes Venture - Series Unknown $323,508,593 June, 01, 2015 -------
Sequoia Capital China No Venture - Series Unknown Undisclosed September, 01, 2012 -------
China Development Bank International Investment Yes Debt Financing $1,500,000,000 January, 10, 2010 -------
Shenzhen Capital Group Yes Grant $12,800,000 January, 01, 2007 -------